ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2011
The effect of the expression of virulence-associated DEAD-box RNA helicase mRNA on the imbalance of Th1-Th2 cytokines in the CSF of patients with Cryptococcus neoformans meningitis.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 7 citations in OpenAlex.
- Immune Modulation and Evasion byACS omega · 2026Review
- Cytokine dynamics in the blood and cerebrospinal fluid of HIV/AIDS patients with cryptococcal meningitis receiving antifungal therapy.Frontiers in cellular and infection microbiology · 2025Article
- Differences in cytokine and chemokine profiles in cerebrospinal fluid caused by the etiology of cryptococcal meningitis and tuberculous meningitis in HIV patients.Clinical and experimental immunology · 2021Article
- A preliminary study on the characteristics of Th1/Th2 immune response in cerebrospinal fluid of AIDS patients with cryptococcal meningitis.BMC infectious diseases · 2021Article
- Chemokine and Cytokine Cascade Caused by Skewing of the Th1-Th2 Balance Is Associated with High Intracranial Pressure in HIV-Associated Cryptococcal Meningitis.Mediators of inflammation · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Virulence-associated DEAD-box RNA helicase (VAD1) is an important factor regulating the virulence of Cryptococcus neoformans. We established a real-time quantitative polymerase chain reaction (PCR) assay to measure the expression of VAD1 mRNA in the cerebrospinal fluid (CSF) of C. neoformans meningitis (CNM) patients, and we also detected the levels of IFN-γ, IL-12 and IL-10 proteins in these CSF samples and controls. Patients with head injuries were selected as controls. We found that the expression of VAD1 mRNA was significantly higher in the acute phase than in the stable phase of CNM. The level of CSF IFN-γ and IL-10 in the acute phase (9.45 pg/ml ± 2.06 and 36.28 pg/ml ± 10.86, respectively) were different to that in the controls (11.89 pg/ml ± 1.75 and 7.33 pg/ml ± 1.68, respectively). The IFN-γ/IL-10 and IL-12/IL-10 ratios were significantly higher in controls than in the acute phase, but lower than in the stable phase. The expression of VAD1 mRNA is inversely related to IFN-γ and is correlated with IL-10 but not to IL-12. The Th2 response is dominant in the acute phase, whereas the immune response switches to a Th1 response in the stable phase. The expression of VAD1 mRNA is related to the imbalance of Th1-Th2 responses, which could be one of the mechanisms by which C. neoformans escapes the immune system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.